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Research Article
IntroductIon
Sepsis can sometimes be difficult to diagnose, and its distinction 
from noninfectious conditions in critically ill patients is often 
a challenge. Relying on clinical features of infection alone is 
challenging as these may not be obvious in some patients.[1] 
A positive culture is considered the most accepted tool to 
diagnose infection; however, this takes 24–48 h, or longer, to 
process.[2] More rapid diagnosis can be achieved using a variety 
of biomarkers, such as C‑reactive protein, procalcitonin, and 
interleukin‑6;[1] however, a minimum lag time of typically 
2–3 h is still present and successes are varied.[2] Therefore, 
other markers must be investigated to assist in making the 
timeliest diagnosis of sepsis.
Sepsis is known to have a negative effect on insulin 
sensitivity (SI).[3‑5] It has been suggested that sepsis induces 
a counter‑regulatory hormone response, i.e., glucagon, 
catecholamines, cortisol, and growth hormone which increases 
insulin resistance thereby decreasing insulin action.[3‑6] Thus, low 
SI and sepsis are strongly linked; however, its effectiveness as a 
diagnostic test of sepsis has only been investigated in few small 
studies outside our local setting.[7,8] Adding to the complexity 
in the study of SI in sepsis is that, not only sepsis, but other 
severe illness and effects through metabolic changes could be 
responsible for a low SI in critically ill patients.[9] A further study 
with more careful methodological framework conducted in our 
local Intensive Care Unit (ICU) is therefore warranted.
SI can be derived using mathematical glucose‑insulin 
models that have had extensive clinical validation.[10‑12] 
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An example of one such model is the intensive control 
of insulin‑nutrition‑glucose (ICING) model, which has 
been rigorously validated within clinically acceptable 
ranges.[12] The model relates the rate of glucose decay to 
the concentration of insulin availability in the interstitium 
to assess SI. In the model’s equations, there is only one 
parameter that needs to be identified which is SI of each 
patient. All other parameters are population constants 
based on prior studies and clinical data, i.e., blood 
glucose (BG) levels, insulin infusion, and glucose input 
rates. SI can be derived at the bedside using application 
software incorporating such model and thus can provide 
real‑time information to the clinicians. Derivation of SI 
does not involve extra procedures or costs outside of those 
required for BG control in the ICU. Despite those reliability 
and simplicity of ICING model, the diagnostic value of 
model‑based SI for sepsis is largely unknown.
The purpose of the present study was to determine the 
levels and diagnostic value of model‑based SI for sepsis in 
critically ill patients. We tested the hypothesis that SI levels 
are significantly lower in sepsis than in nonsepsis and thus 
able to discriminate these two groups of patients with a good 
performance in the critical care setting.
MaterIals and Methods
Study designs and participants
This was a retrospective cohort study performed in the ICU 
of a major tertiary hospital in Pahang, Malaysia, from June 
2014 to May 2016. The inclusion criteria were consecutive 
adult patients who received insulin infusion in the first 24 h 
of their ICU admission. The insulin infusion protocol was 
based on the guideline for BG management in the ICU by the 
Malaysian Society of Intensive Care (2012).[13] The guideline 
recommends to perform BG level on ICU admission and 
start the protocol when the BG exceeds 10 mmol/L for two 
consecutive readings, 1 h apart. The aim was to maintain BG 
between 6 and 10 mmol/L.
All patients in whom the diagnosis of diabetes mellitus (DM) 
Type I or Type II was known from their past medical history 
were excluded from the study to remove any bias from their 
lower SI due to DM. Such diagnosis was usually made by their 
primary care physicians and for the most common form of DM, 
i.e., Type II, this was based on the criteria outlined in the local 
clinical practice guideline by Ministry of Health Malaysia.[14] 
Patients were also excluded if their ICU admission was <24 h 
or if the data required to calculate SI were incomplete. The 
study was approved by the Local Medical Research and Ethics 
Committee and was registered under the National Medical 
Research Registry (NMRR‑13‑1592‑18706). A waiver of 
consent was approved due to the retrospective nature of the 
study.
Glucose‑insulin system model
The glucose‑insulin system model used in this study is the 
ICING model and is listed in equations (1) to (7) [Appendix 1].[12] 
In these equations, there is only one parameter that needs to 
be identified which is SI of each patient. All other parameters 
are population constants based on prior studies and clinical 
data, i.e., BG levels, insulin infusion, and glucose input rates 
[Appendix 1]. By fitting these population, constants and 
clinical data into the model’s equations, SI of each patient 
can be derived.
Data collection
We reviewed the ICU chart to obtain baseline demographic 
and clinical data including age, sex, body mass index, initial 
Simplified Acute Physiological Score II, Sequential organ 
failure assessment score, septic shock, comorbidities as 
assessed by Charlson Comorbidity Index, treatment received 
in the first 24 h, length of ICU, and hospital stays and ICU 
mortality. Patients who were admitted with sepsis were 
confirmed clinically by the judgement of senior intensive care 
clinicians and/or by positive blood culture. Sepsis and septic 
shock were defined according to the American College of 
Chest Physicians/Society of Critical Care Medicine Consensus 
Conference.[15] Patients who were nonsepsis were deemed so 
if there was no suspicion of infection and by negative blood 
culture. To derive the SI profiles, we collected BG levels, 
insulin infusion and glucose input rates that the patients 
received at 1 (baseline), 4, 8, 12, 16, 20, and 24 h of their 
ICU admission.
Statistical analysis
Data are presented as mean ± standard deviation or median 
(interquartile range), and comparison of variables between 
the sepsis and nonsepsis groups was analyzed using 
independent t‑test or Mann–Whitney test. Normality of data 
was tested with Shapiro–Wilk test. Categorical variables are 
presented as frequency (percentage) and were compared with 
Chi‑squared test. Changes in mean BG over time between 
the two groups were compared using repeated‑measures 
analysis of variance (ANOVA). The diagnostic performance 
of the model‑based SI was assessed by the area under 
the receiver operating characteristic curve (AUROC) of 
the sensitivity against 1‑specificity across a series of SI 
readings. The AUROC ranges from 0.5 (no discrimination) 
to 1 (perfect discrimination).[16,17] Clinical validity is assumed 
at an AUROC of more than 0.7. The optimal cutoff point was 
defined as the measured quantity, which maximized sensitivity 
and specificity. The sensitivity, specificity, predictive values, 
and likelihood ratios of the test at the optimal cutoff point 
were calculated. Statistical analysis was performed using 
SPSS version 24.0 (IBM, Armonk, NY, USA) and MedCalc 
for Windows, version 17.5.5 (MedCalc Software, Ostend, 
Belgium).
Sample size calculation
A minimum sample size of 10 sepsis and 10 nonsepsis patients 
was required to achieve the relevant anticipated AUROC of 
0.8, based on the diagnostic performance of the SI test in a 
previous study,[7] at a significance level of 5%, power of 80%, 
and allocation ratio of 1.
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results
Baseline demographics, clinical characteristics, and 
outcomes
Throughout the study, a total of 210 patients requiring 
insulin infusion protocol were screened for eligibility, of 
whom 38 patients were included and classified to the sepsis 
group (n = 18) or the nonsepsis group (n = 20) [Figure 1]. 
The baseline demographics, clinical characteristics, and 
outcomes as stratified by sepsis status are presented in 
Table 1. Patients with sepsis were younger (P = 0.036) 
and mostly were medical cases (P = 0.001) compared with 
nonsepsis. Most patients in the sepsis group had respiratory 
as their primary diagnosis class (P = 0.001), whereas 
most nonsepsis was classified as trauma (P < 0.0001). 
Antibiotic use was higher in the sepsis group for obvious 
reason (P < 0.0001), although 7 or 35% of patients in 
the nonsepsis group also required antibiotic for surgical 
prophylaxis. The rate of positive blood culture in the sepsis 
group was 28.6%. In relation to outcome, the in‑hospital 
mortality rate was significantly higher in those diagnosed 
with sepsis compared with nonsepsis (P < 0.0001).
Blood glucose, insulin infusion, and glucose input profiles
The BG levels over the entire study duration for all patients 
in both sepsis and nonsepsis groups are shown in Figure 2. 
Repeated‑measures ANOVA showed BG was higher in the 
sepsis group compared to the nonsepsis group (P = 0.005) and 
significant effect of time (P < 0.0001). The mean intravenous 
insulin received in the first 24 h was higher in sepsis compared 
with nonsepsis with the difference approaching statistical 
significance (37.5 ± 16.6 vs. 28.4 ± 10.8 IU, P = 0.051). 
The mean enteral glucose input in the first 24 h was lower in 
those with sepsis compared with nonsepsis (58.1 ± 51.1 vs. 
95.5 ± 42.8 mg, P = 0.019). There was no statistically 
significant difference in the mean parenteral glucose input 
between the sepsis and nonsepsis groups (72.9 ± 108.7 vs. 
57.1 ± 58 Gm, P = 0.575).
Insulin sensitivity profiles
Median changes in SI (×10−4 L/mu/min) during the first 24 h 
of ICU admission are shown in Table 2. At all follow‑up time 
points, SI was lower in patients who were diagnosed with 
sepsis than those without sepsis (P < 0.05). SI decreased from 
baseline to hour 4 in the nonsepsis group, but gradually increased 
thereafter although it did not attain the baseline value by h 24. 
Changes in SI are more variable in the sepsis group; however, the 
general trend is an increase from the baseline to h 24 of ICU stay.
Table 1: Baseline demographics, clinical characteristics, 
and outcomes of nonsepsis and sepsis
Variables Nonsepsis 
(n=20)
Sepsis 
(n=18)
P
Demographic
Age (years) 56±12 45±17 0.036
Sex (male) 15 (75) 8 (44) 0.054
BMI (kg/m2) 26.5±3.5 26.6±6.2 0.971
Clinical
Admission category
Medical 5 (26.3) 14 (73.7) 0.001
Surgical 15 (78.9) 4 (21.1)
Primary diagnosis
Respiratory 2 (10) 8 (44.4) 0.016
Trauma 10 (50) 0 <0.0001
Soft tissue 1 (5) 4 (22.2) 0.117
Neurological 2 (10) 1 (5.6) 0.612
Abdominal 1 (5) 2 (11.1) 0.485
Renal 0 2 (11.1) 0.126
Others 4 (20) 1 (5.6) 0.168
Severity of illness
SAPS II 41±12 44±16 0.757
SOFA 6±3 8±4 0.198
Septic shock ‑ 13 (72.2) ‑
Charlson Comorbidity 
Index
2 (0.3‑2) 1 (0‑3.5) 0.942
Treatment in first 24 h
Intravenous fluid 15 (75) 15 (83.3) 0.529
Antibiotic 7 (35) 18 (100) <0.0001
Inotropic or vasopressor 17 (85) 13 (72.2) 0.335
Corticosteroids 4 (20) 6 (33) 0.351
Mechanical ventilation 20 (100) 18 (100) ‑
Renal replacement 
therapy
3 (15) 6 (33.3) 0.184
Surgical intervention 6 (30) 4 (22.2) 0.587
Positive blood culture 0 4 (28.6) 0.026
Outcome
Length of ICU 
stay (days)
15.5 (10.3‑19.8) 14.5 (11‑36.5) 0.393
Length of hospital 
stay (days)
26 (17‑35.5) 31 (18.8‑48) 0.239
In‑hospital mortality 9 (45) 10 (55.6) <0.0001
Data are expressed as mean±SD, frequencies (%), or median (interquartile 
range). The results of the comparison between the two groups were analyzed 
by independent t‑test, the Mann‑Whitney test for continuous variables or 
the Chi‑squared test for categorical variables. BMI: Body mass index; 
SAPS II: Simplified Acute Physiological Score II; SOFA: Sequential Organ 
Failure Assessment; ICU: Intensive Care Unit; SD: Standard deviation
Consecutive adult patients
requiring intravenous insulin
infusion protocol
in the first 24 hours of ICU
admission (n = 210)
Exclusion:
Presence of type I or
type II diabetes
mellitus (n = 112)
Incomplete information
to calculate insulin
sensitivity (n = 60)
Included in the
study (n = 38)
Sepsis (n = 18) Non-sepsis (n = 20)
Figure 1: Flowchart of patient selection
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Diagnostic performance of insulin sensitivity
Table 3 shows the AUROC of the model‑based SI for the 
diagnosis of sepsis. The AUROC of the test was more than 
0.8 at majority of the time points, which suggested its good 
performance for discriminating sepsis from nonsepsis. At 
baseline, at the optimal cutoff value of 1.573 × 10−4 L/mu/min, 
the sensitivity and specificity of model‑based SI were 77.8% 
and 72%, respectively. The positive predictive value was 
73.7%, the negative predictive value was 78.9%, the positive 
likelihood ratio was 2.8, and the negative likelihood ratio 
was 0.3.
dIscussIon
This retrospective single‑center study was carried out to 
provide proof of concept and preliminary information on 
the usefulness of model‑based SI as a real‑time marker of 
sepsis in critically ill nondiabetic patients. The median value 
of model‑based SI in healthy volunteers established from a 
previous study is 14.225 L/mu/min.[18] A markedly reduced SI 
from the value during health was demonstrated in our cohort 
regardless of their sepsis status indicating that SI was affected 
by critical illness. When analyzed by their sepsis status, SI 
within 24 h of ICU admission were significantly lower in 
patients diagnosed with sepsis than in those without sepsis. In 
both groups of patients, SI tended to increase over time which 
we postulate may be due to improvement in condition of the 
patients as critical care therapy and monitoring began. Analysis 
of the receiver‑operating characteristic curve assumed that the 
model‑based SI was a clinically valid marker with an AUROC 
more than 0.7 at each follow‑up time point.
In a retrospective study of 30 patients with sepsis conducted 
in a Christchurch ICU, similar to our study, significant 
relationship between lower SI and presence of sepsis was 
observed.[8] However, the median SI of their sepsis cohort 
was 4.153 × 10−4 L/mU/min. The SI was markedly lower in 
our sepsis patients; 0.573 × 10−4 L/mU/min. We postulated 
that lower SI in our cohort is due to the high prevalence of 
undiagnosed DM in our population although this postulation 
needs to be ascertained. Lower SI in our cohort yielded to a 
lower cutoff point of the baseline SI test observed in our study, 
1.573 × 10−4 L/mU/min, compared to 4.5 × 10−4 L/mU/min in 
the previous study.[8]
In another retrospective study of 143 critically ill patients, 
low SI was found not useful as a sepsis diagnostic test with 
a low positive predictive value of 2.8%, but a far higher 
negative predictive value of 99.8% was observed making the 
test suitable for ruling out but not for ruling in sepsis.[7] In our 
study, we found that low SI was able to diagnose sepsis with 
84.2% certainty, while high SI ruled out sepsis with 88.9% 
certainty. The positive results could be due to the consequence 
of higher sepsis severity in our cohort; 72.2% of our patients 
were in septic shock on admission compared to 9.8% in the 
previous study.[7] This agrees to the hypothesis that greater 
severity of sepsis yields to better prediction of the condition 
using SI.[8] In both of the previous studies,[7,8] many potential 
confounders on SI were not recorded. For example, low SI 
can be exacerbated by the use of corticosteroids,[19,20] which 
are sometimes indicated in the treatment of sepsis.
Biomarker tests have been developed to facilitate early diagnosis 
of sepsis; however, they still suffer some disadvantages. Over 
the last several decades, C‑reactive protein and more recently 
procalcitonin and interleukin‑6 have emerged as biomarkers 
for identifying sepsis. However, these biomarkers have been 
Table 2: Insulin sensitivity profiles (×10−4 L/mU/min) in 
the first 24 h of Intensive Care Unit admission and their 
diagnostic performance for sepsis
Time from 
admission (h)
Nonsepsis 
(n=20)
Sepsis (n=18) P
0 3.596 (1.368‑8.329) 0.573 (0‑1.686) 0.001
4 2.269 (1.47‑3.289) 0.882 (0.287‑1.542) 0.001
8 3.356 (2.137‑4.425) 1.819 (0.641‑0.309) 0.007
12 3.517 (2.603‑4.995) 1.347 (0.801‑2.729) 0.001
16 4.279 (2.565‑5.237) 2.349 (0.932‑2.847) 0.001
20 4.453 (2.693‑5.174) 1.799 (0.668‑2.887) <0.0001
24 4.351 (3.606‑5.437) 1.929 (1.262‑3.093) <0.0001
Data are expressed as median (interquartile range). The results of the 
comparison between the two groups were analyzed by Mann‑Whitney test
Table 3: Diagnostic performance of model‑based insulin 
sensitivity for sepsis
AUROC (95% CI) Cut‑off (×10−4 
L/mU/min)
Sensitivity 
(%)
Specificity 
(%)
0 h 0.814 (0.675‑0.953) 1.573 77.8 75
4 h 0.814 (0.672‑0.956) 1.7 83.3 75
8 h 0.751 (0.594‑0.909) 2.503 72.2 70
12 h 0.808 (0.656‑0.961) 2.382 77.8 90
16 h 0.803 (0.661‑0.944) 2.659 72.2 75
20 h 0.878 (0.770‑0.985) 3.06 83.3 75
24 h 0.872 (0.748‑0.996) 3.142 83.3 80
AUROC: Area under the receiver operating characteristic curve; 
CI: Confidence interval
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Figure 2: The blood glucose profiles (in mmol/L) in the first 24 h 
of admission of nonsepsis and sepsis. Data are expressed as 
mean ± standard deviation
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used with varying success.[21] Furthermore, as with other 
test measured in the laboratory, by the time, the results are 
available to the clinicians, they may not represent the current 
status of the highly dynamic critically ill patients. SI can 
be measured hourly at the bedside and thus could provide 
real‑time information to the clinicians. Obtaining the value 
of SI does not rely on processing of the test in the laboratory. 
This could avoid delay in the decision‑making and treatment 
as with tests that are measured in the laboratory. Measurement 
of SI does not involve extra procedure or costs outside of those 
required for BG control in the ICU. Thus, SI has the potential 
to be cost‑effective enough that it can be utilized routinely in 
patients’ diagnosis.
This study has several pertinent limitations. First, patients who 
have Type I or Type II DM were excluded from this study. The 
prevalence of Type II DM is high in some ICU settings.[22,23] 
Thus, additional studies on this specific cohort must be done 
to extend the methods used here for application in those cases. 
Second, patients with undiagnosed DM as well as those in the 
prediabetic state may have not been excluded from our study 
contributing to lower SI being observed. Approximately 12% 
of all hyperglycaemic patients being admitted to ICU have no 
previous diagnosis of DM.[24] This limitation can be overcome 
in future studies by screening the patients using hemoglobin 
A1c on admission. Third, as model‑based SI was only studied 
in hyperglycemic patients who received intravenous insulin 
infusion, our results is of limited clinical applicability to the 
general ICU population. Fourth, in addition to testing the 
model‑based SI as a standalone biomarker, its performance 
could have been compared with classic or well‑studied 
biomarkers such as procalcitonin and interleukin‑6. Last, 
the results that we generated in this study predicted our 
single‑centered data set, but whether it is generalizable to 
external populations is unknown.
conclusIons
Presence of sepsis was associated with a significantly lower 
SI levels in our critically ill non‑diabetic patients. Sepsis can 
be ruled out when model‑based SI is above 1.573 x10‑4 L/mu/
min and can be ruled in when SI is below the cut‑off, with 
fairly high sensitivity and specificity. This preliminary study 
showed the potential of model‑based SI as a new diagnostic 
marker for sepsis in critically ill non‑diabetic patients. The 
findings can be used as a foundation for further, prospective 
investigation in this area.
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nomenclatures 
 
 
?̇?𝐺 =  − 𝐺𝐺(𝑡𝑡)𝑝𝑝𝑝𝑝 −  𝑆𝑆1𝐺𝐺(𝑡𝑡) 𝑄𝑄(𝑡𝑡)1 + 𝛼𝛼𝑝𝑝𝑄𝑄(𝑡𝑡) +  𝑃𝑃(𝑡𝑡) + 𝐸𝐸𝐺𝐺𝑃𝑃𝑏𝑏 − 𝐶𝐶𝐶𝐶𝑆𝑆𝑉𝑉𝑝𝑝  
 
(1) 
?̇?𝑄 =  𝑛𝑛𝑖𝑖[𝐼𝐼(𝑡𝑡) − 𝑄𝑄(𝑡𝑡)] −  𝑛𝑛𝐶𝐶 𝑄𝑄(𝑡𝑡)1 + 𝛼𝛼𝑝𝑝𝑄𝑄(𝑡𝑡) 
 
(2) 
𝐼𝐼̇ =  −𝑛𝑛𝐾𝐾𝐼𝐼(𝑡𝑡) −  𝑛𝑛𝐿𝐿𝐼𝐼(𝑡𝑡)1+𝛼𝛼𝐼𝐼𝐼𝐼(𝑡𝑡) −  𝑛𝑛𝑖𝑖[𝐼𝐼(𝑡𝑡) − 𝑄𝑄(𝑡𝑡)] + 𝑢𝑢𝑒𝑒𝑒𝑒(𝑡𝑡)𝑉𝑉𝐼𝐼  + (1-𝑥𝑥𝐿𝐿) 𝑢𝑢𝑒𝑒𝑒𝑒𝑉𝑉𝐼𝐼  
 
(3) 
𝑃𝑃1̇ =  −𝑑𝑑1𝑃𝑃1 + 𝐷𝐷(𝑡𝑡) 
 
(4) 
𝑃𝑃2̇ =  −min (𝑑𝑑2𝑃𝑃2,𝑃𝑃𝑚𝑚𝑚𝑚𝑚𝑚) + 𝑑𝑑1𝑃𝑃1 
 
(5) 
𝑃𝑃(𝑡𝑡) = min(𝑑𝑑2𝑃𝑃2,𝑃𝑃𝑚𝑚𝑚𝑚𝑚𝑚) + 𝑃𝑃𝐶𝐶(𝑡𝑡) 
 
(6) 
𝑢𝑢𝑒𝑒𝑛𝑛(𝑡𝑡) =  𝑘𝑘1𝑒𝑒−𝐼𝐼(𝑡𝑡)𝑘𝑘2𝑘𝑘3  ; when C-peptide data is not available (7) 
 
